---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-24-000082"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:33:57.199410+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Edwards completes $4.2B sale of Critical Care to BD, adds $1.5B buyback

## Summary
- Closed all-cash sale of Critical Care to BD (NYSE: BDX) for $4.2B.
- Board authorized additional $1.5B share repurchase; entered $500M accelerated repurchase.
- Total $1B repurchased to date including prior $500M 10b5-1 and open-market buys.
- Net proceeds to fund strategic initiatives, prior acquisitions, and share repurchases.
- Company to discuss strategy and outlook at Wells Fargo Healthcare Conference on Sept 5.

## SEC filing metadata
- accession: 0001099800-24-000082
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/0001099800-24-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/ew-20240903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-24-000082
- JSON: https://secwatch.observer/filing/0001099800-24-000082.json
- Plain text: https://secwatch.observer/filing/0001099800-24-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.